MIVT ANOUNCES NEW 'SMART' DRUG-DELIVERY SYSTEMS
Vancouver, British Columbia-based MIV Therapeutics (MIVT), which develops next-generation biocompatible stent coatings and drug delivery technologies for the treatment of cardiovascular disease, recently announced the development of a new drug-delivery system incorporating "smart" drug-eluting coating technologies. The new delivery system is specifically designed to benefit patients who require the controlled, gradual release of drugs from implanted medical devices.
According to MIVT, this new "smart" drug eluting system is designed to improve the overall biocompatibility of polymer composites and to increase the control of drug-delivery characteristics. Engineering specifications used in this system provide considerably improved drug release flexibility, including the option of releasing a wide variety of drugs to address the various needs of a patient's particular pathological condition over extended periods of time. This "smart" coating technology carries with it the promise of providing highly personalized and optimal therapeutic benefits to patients who require implantable medical devices.